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ABSTRACT 
Objective: Resveratrol and vitamin-C combination was evaluated for its antidiabetic and antioxidant activity in streptozotocin (STZ) induced 
diabetic rats.  
Methods: The wistar rats were challenged with a single intra peritoneal injection of STZ (50 mg/kg). The rats were treated with graded oral dose of 
10 mg/kg of resveratrol and 0.9 g/kg of Vitamin C for 21 days. The fasting blood glucose levels were monitored for all animals in 1,7,14 and 21 days 
of drug treatments by using glucometer. The liver homogenate was used for estimation of proteins, malondialdehyde (MDA), lipid hydroperoxide 
(LH), Super Oxide Dismutase (SOD), Catalase (CAT), Glutathione reductase (GSSH) and Reduced glutathione (GSH). 
Results: Resveratrol with vitamin C combination showed significant (P<0.01) increase in body weight, total protein, and significant (P<0.01) 
decrease in fasting blood sugar level, MDA and LH, when compared to diabetic control. Resveratrol and vitamin C significantly (P<0.01) restored the 
levels of both enzymatic (SOD, CAT, GSSH) and non enzymatic antioxidant enzymes (GSH) which are almost similar to the control.  
Conclusion: Resveratrol and vitamin C both is having antioxidant activity, but the combination showed synergistic antioxidant & antidiabetic 
activity. Thus, the present study provides a significant rationale for the management of diabetes. 
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INTRODUCTION 
Diabetes Mellitus, a metabolic disorder of multiple etiologies, is 
characterized by chronic hyperglycemia with disturbances of 
carbohydrate, fat and protein metabolism that result from 
imperfections in insulin secretion, insulin action or both [1]. The 
increase in the incidence of diabetes is due to longevity of life, 
changing lifestyle, obesity, sedentary work, changing dietary 
patterns and low birth weight [2]. The poly phenolic compound 
resveratrol which is also known as 3,4’,5 trihydroxy stilbene [3] and 
3,4’,5-stilbenetriol, exists in cis-and trans stereo isomeric forms 
commonly found in grapes and wines particularly red wine. It is 
synthesized from pcoumaroyl CoA and malonyl CoA. It is a naturally 
occurring phytochemical found in many plants. 
The antioxidant role of resveratrol supports recent research in a 
protective mechanism through increasing endogenous cellular 
antioxidant defences. Resveratrol has been discovered as an 
antiproliferative agent for cancer [4], the cardiac protective ability 
[5] effective against diabetes [6] and also protective effect on most of 
the vital organs including kidney, heart, and brain from ischemic 
reperfusion injury. The protective mechanism of resveratrol 
includes its role as intracellular antioxidant, anti-inflammatory agent 
and its ability to induce nitric oxide synthase (NOS) expression with 
a dose of (10 mg/kg) [7]. Most of biological protective actions of 
resveratrol have been associated with its antioxidative, anti-
inflammatory, and antiapoptotic properties and other indirect 
pathways [8]. Continued public interest and increasing resveratrol 
supplements on the market warrant a review of the available in vitro 
and in vivo science reported in the Diabetic-related literature. 
Rigorous clinical trials evaluating the effects of resveratrol in 
diabetes mellitus are absent, though the general population 
consumption appears to be relatively safe. Resveratrol has shown 
potential for treating diabetes in laboratory animals. 
Vitamin C or L-ascorbic acid is an essential nutrient for humans. It 
has several medicinal properties like antioxidant, anticancer, effect 
on coronary artery diseases [9], diabetes [10] with the dose of 
(0.9g/kg) etc. So the present study was undertaken to evaluate the 
synergistic effect of resveratrol and vitamin-c the combination in 
streptozotocin-induced diabetic rats. 
MATERIALS AND METHODS 
The chemicals required for this study were obtained from 
(Resveratrol and Vitamin-C) Sigma chemicals, Streptozotocin from 
Himedia. 
Preparation of resveratrol and vitamin C suspensions  
The Resveratrol suspension was prepared by dissolving Resveratrol 
in 0.5% carboxymethylcellulose solution. Vitamin C suspension also 
prepared in 0.5% CMC solution. All these drugs were administered 
in a constant volume of 0.5 ml/100g body weight of the rat. 
Experimental animals  
Wistar rats (120-150g) were obtained from the animal house and 
they were maintained in clean, sterile, polypropylene cages with 
paddy husk as bedding. Animals were housed at temperature of 
25±2 °C and relative humidity of 30-60%. A 12:12 h light and dark 
cycle was followed. The animals had free access to food and de 
mineralised drinking water ad libitum. All the experimental 
procedures and protocols used in this study were reviewed by the 
Institutional animal ethics committee (688/2/C-CPCSEA) of NCP and 
were in accordance with the guidelines of the IAEC. 
Experimental protocol 
30 Male Wister albino rats were divided into five groups of 6 
animals in each group. 
Induction of diabetes mellitus  
Male wistar rats (120-150g) were fasted for overnight before 
challenging with a single injection of freshly prepared streptozotocin 
(50 mg/kg) intraperitonially, and injected within 5 min of 
preparation to prevent degradation. After administration of 
streptozotocin, the animals had free access to food and 
dematerialized drinking water ad libitum. The development of 
hyperglycemia in rats was confirmed by fasting serum glucose 
estimation of 48 h on post streptozotocin injection. The rats with 
fasting serum glucose level of above 200 mg/dl were considered 
diabetic and included in the study. The test dose was administered 
orally for 21 days as follows; 
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 Group-I Vehicle control received Normal saline (10 ml/kg) 
Group-II Rats received streptozotocin (50 mg/kg) 
Group-III STZ induced diabetic rats received Glibenclamide (0.5 mg/kg) 
Group-IV STZ induced diabetic rats received Resveratrol (10 mg/kg) 
Group-V STZ induced diabetic rats received Vitamin C (0.9g/kg) 
Group-VI  STZ induced diabetic rats received Resveratrol (10 mg/kg) with Vitamin C 0.9g/kg) combination  
 
The fasting blood glucose levels were monitored for all animals in 
1,7,14 and 21 days of drug treatments by using glucometer. Blood 
was collected from tail tip of the animals after 3 hours of drug 
administration and the fasting blood glucose levels were compared 
with that of diabetic control group animals. 
The rats were sacrificed on the 22th
The normal control rats were gained body weight during the 
experimental period. STZ induced diabetic rats showed a severe loss 
of body weight throughout the experimental period. Administration 
of standard drug glibenclamide, resveratrol, vitamin C and 
resveratrol with vitamin C combination showed significant (P<0.01) 
increase in body weight compared to diabetic rats. Results suggested 
that resveratrol alone, vitamin C alone and resveratrol with vitamin 
C treatment has a positive effect on maintaining body weights in 
diabetic rats. The resveratrol with vitamin C combination treated 
rats gained more weight than the standard drug (table 1).  
 day and their liver was excised, 
rinsed in ice cold normal saline followed by 0.15 M Tris-HCL buffer. The 
homogenate was used for estimation of proteins [11], malondialdehyde 
and lipid hydroperoxide [12]. Part of homogenate after precipitating 
proteins with trichloroacetic acid (TCA) was used for the estimation of 
GSSH [13] and GSH [14]. The rest of the homogenate was centrifuged at 
15000 rpm for 15 min at  4 ° C. The supernatant thus obtained was used 
for the estimation of SOD [15] and CAT [16]. 
RESULTS AND DISCUSSION 
The Resveratrol (10 mg/kg) and Vitamin-C (0.9g/kg) treated groups 
shown a significant (P<0.01) decrease in fasting blood sugar level, 
when compared to diabetic rats. The resveratrol & Vit C combination 
exhibited maximum glucose lowering effect in diabetic rats 
compared to resveratrol and Vit C treated rats. Glibenclamide 
exhibited a % reduction in blood glucose levels at the end of the 
study when compared to diabetic control (table 2). 
Treatment with STZ showed a significant (P<0.01) decrease in the 
level of total protein and an increase in the level of malondialdehyde 
(MDA) and lipid hydroperoxides (LH) when compared to normal 
control. Treatment with the resveratrol and vitamin C caused a 
significant (P<0.01) decrease in the MDA and LH and an increase in 
total protein content (table 3). 
Treatment with STZ produced a significant (P<0.01) decrease in the 
enzymatic antioxidants like catalase, superoxide dismutase, and 
glutathione reductase and the non-enzymatic antioxidant reduced 
glutathione in the lens homogenate when compared to normal 
control. Treatment with the resveratrol and vitamin C significantly 
(P<0.01) restored the levels of both enzymatic and non enzymatic 
antioxidant enzymes which is almost similar to the control group 
(table 4). 
 
Table 1: Effect of resveratrol and vitamin-C combination on body weight changes in streptozotocin induced diabetic rats 
Groups Change in body weight (g) 
Normal  36.8±3.6 
Diabetic   20.6±2.6
Diabetic+Glibenclamide 
a 
 35.4±4.6
Diabetic+Resveratrol 
b 
 32.8±1.8
Diabetic+Vit C 
b 
 34.6±3.4
Diabetic+Resveratrol+Vit C 
b 
 35.6±3.4b 
Values are mean±SD; n=6 in each group; aP<0.01 when compared to normal control; b
 
P<0.01, when compared to diabetic control (one way ANOVA 
followed by Dunnett’s test). 
Table 2: Effect of resveratrol and vitamin-C combination on fasting blood glucose level of streptozotocin induced diabetic rats 
Groups 3rd 7 day th 14 day th 21 day th day 
Normal 82.5±7.3 84.9±6.2 81.3±8.8 83.9±7.8 
Diabetic 238.5±13.6 256.8±18.9a 271.5±23.2a 261.7±3.4a 
Diabetic+Glibenclamide 
a 
216.3±14.9 185.3±12.5c 152.3±10.3c 118.7±1.6c 
Diabetic+Resveratrol 
c 
230.6±9.8 201.4±12.4b 185.1±12.6c 174.1±5.3c 
Diabetic+Vit C 
c 
226.8±10.4 198.1±11.6c 192.2±15.7c 138.7±1.8c 
Diabetic+Resveratrol+Vit C 
c 
216.8±12.4 181.1±13.8c 162.5±13.4c 126.7±1.8c c 
Values are mean±SD; n=6 in each group; aP<0.01 when compared to normal control; bP<0.05,c
 
P<0.01, when compared to diabetic control (one way 
ANOVA followed by Dunnett’s test). 
Table 3: Effect of resveratrol and vitamin-C combination on liver protein, MDA and LH in control and experimental animals 
Groups Protein 
(moles/min/mg wet tissue) 
MDA 
(nmoles/min/mg protein) 
LH 
(nmoles/min/mg protein) 
Normal 1.78±0.07 0.72±0.005 0.54±0.03 
Diabetic  1.02±0.06 1.26±0.08a 1.06±0.02a 
Diabetic+Glibenclamide 
a 
1.45±0.08 0.91±0.02c 0.68±0.06c 
Diabetic+Resveratrol 
c 
1.28±0.05 1.08±0.06c 0.92±0.05b 
Diabetic+Vit C 
c 
1.39±0.1 0.94±0.04c 0.76±0.02c 
Diabetic+Resveratrol+Vit C 
c 
1.51±0.09 0.88±0.05c 0.72±0.04c c 
Values are mean±SD; n=6 in each group; aP<0.01 when compared to normal control; bP<0.05,cP<0.05, when compared to diabetic control (one way 
ANOVA followed by Dunnett’s test). 
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Table 4: Effect of resveratrol and vitamin-C combination on liver enzymatic and non enzymatic antioxidants in control and experimental 
animals 
Groups 
 
CAT 
(μmoles/min/mg 
protein) 
SOD 
(nmoles/min/mg 
protein) 
GSSH 
(nmoles/min/mg 
protein) 
GSH 
(nmoles/min/mg 
protein) 
Normal 48.6±3.8 4.6±0.3 32.8±3.2 12.6±0.9 
Diabetic  36.2±4.2 3.2±0.2a 21.2±1.6a 9.2±0.92a 
Diabetic+Glibenclamide 
a 
46.3±3.8 4.4±0.4c 32.6±3.1c 12.2±1.1c 
Diabetic+Resveratrol 
c 
39.6±2.9 3.9±0.3 29.5±2.8c 10.9±0.8c 
Diabetic+Vit C 
c 
42.6±4.1 4.1±0.4b 30.9±3.2c 11.2±1.2c 
Diabetic+Resveratrol+Vit C 
c 
44.6±4.3 4.3±0.2c 30.6±2.7c 11.8±0.7c c 
Values are mean±SD; n=6 in each group; aP<0.01 when compared to normal control; bP<0.05,c
 
P<0.01, when compared to diabetic control (one way 
ANOVA followed by Dunnett’s test). 
Diabetes mellitus (DM) is a metabolic disorder principally 
characterized by elevated blood glucose levels and by micro vascular 
and macro vascular complications that considerably increase the 
morbidity and mortality related to the disease[17]. Around 150 
million peoples are suffering from diabetic complications in the 
world. This disorder was associated with an increased production of 
reactive oxygen species (ROS) in both humans and animals. 
Induction of oxidative stress is a key process in the onset on diabetic 
complications. The mechanisms and pathways involved are complex. 
ROS are produced by mitochondria and various enzymes, including 
NADPH oxidase, xanthine oxidase, and NOS. The STZ induced 
diabetes provides a relevant example of endogenous chronic 
oxidative stress and hyperglycemia. STZ induced diabetes provides a 
relevant example of endogenous chronic oxidative stress and 
hyperglycemia. 
Oxidative stress plays a major role in the pathogenesis of both types 
of diabetes mellitus. In-vivo studies of the effect of various herbal 
drugs on diabetes mellitus with the aim of establishing the 
relationship between the free radicals, diabetes and its complication. 
In diabetes hypo insulinemia increases the activity of the enzymes 
which initiate oxidation of fatty acids, results in lipid peroxidation. 
Increased lipid peroxidation impairs membrane functions by 
decreasing membrane fluidity that leads to cell injury and damage 
[18] STZ-induced hyperglycaemia has been described as a useful 
experimental model to study the activity of hypoglycemic agents 
[19]. STZ selectively destroyed pancreatic insulin secreting β–cells, 
leaving less active cell resulting in a diabetic state [20]. 
Many secondary metabolites participate in a variety of anti-diabetic 
functions in vivo [21]. Resveratrol is a poly phenolic compound and 
Vitamin-C; both are antioxidants and showed antidiabetic activity. 
Therefore the present study is designed to evaluate the synergistic 
effect of resveratrol and vitamin-C combination in STZ-induced 
diabetic rats.  
In the present study, the groups of normal rats have shown a gain 
body weight and fasting blood glucose levels were maintained in the 
normal range. STZ-injected rats showed the symptoms of diabetes 
mellitus such as hyperglycemia and growth retardation. It has also 
been observed that significantly increased fasting blood glucose in 
this group. The improvement in body weight gain in diabetic rats 
supplemented with resveratrol, vitamin C and resveratrol with 
vitamin C combination highlight the blood glucose homeostasis 
which in turn promotes the body weight gain. 
Elevated blood glucose levels observed in the diabetic rats were 
significantly decreased in resveratrol, vitamin C and resveratrol with 
vitamin C combination treated groups suggesting insulin stimulated 
effect of resveratrol, vitamin C and resveratrol with vitamin C 
combination from the remnant β-cells. This was further evidenced 
that these drugs have anti diabetic property.  
CONCLUSION 
The experimental evidence obtained in the present laboratory 
animal study indicates that resveratrol with vitamin C combination 
was much more effective in diabetic complications compared to 
resveratrol and vitamin C alone. This may be due to enhancing effect 
on cellular antioxidant defences to protect against oxidative damage 
of resveratrol and vitamin C. 
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